Compound Detail
CHEMBL4594328
BEREMAGENE GEPERPAVEC 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL4594328 |
| Name | BEREMAGENE GEPERPAVEC |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
5
Known Names
5
Indications
1
Mechanisms
Drug Information
| Molecule Type | Gene |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Collagen alpha-1(VII) chain exogenous gene | EXOGENOUS GENE | Collagen alpha-1(VII) chain | ✓ | ✓ |
Indications
Epidermolysis Bullosa Dystrophica Epidermolysis Bullosa Dystrophica Epidermolysis Bullosa Dystrophica Skin Ulcer Wounds and Injuries
ATC Classification
D03AX16
beremagene geperpavec
Level 1: DERMATOLOGICALS
Level 2: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
Data from ChEMBL 36 via Core Engine